Exploratory observational study of famitinib malate combined with camrelizumab in third-line and post-third-line treatment of colorectal cancer
Latest Information Update: 31 Jul 2020
At a glance
- Drugs Camrelizumab (Primary) ; Famitinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Jul 2020 New trial record